open access

Vol 5, No 2 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-04-02
Get Citation

Growing and sexual development and IGF-1, its binding proteins IGFBP-1 and IGFBP-3 in children and adolescents with type 1 diabetes mellitus

Anna Wędrychowicz, Hanna Dziatkowiak, Joanna Nazim, Krystyna Sztefko
Diabetologia Praktyczna 2004;5(2):57-66.

open access

Vol 5, No 2 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-04-02

Abstract

INTRODUCTION. The aim of the study was evaluation of the somatic development and sexual maturation of children and adolescents with type 1 diabetes mellitus and estimation of their IGF-IGFBP system at the on-set of diabetes as well as during the progress of the disease. It was also analysed how the methods of insulinotherapy influence estimated growth factors and auxology parameters.
MATERIAL AND METHODS. 148 diabetic patients without other diseases treated with conventional and intensive insulinotherapy with diabetes duration 0-21 years and 54 age-matched healthy children and adolescents 2–22 years old were included into the study. Their somatic and pubertal development were estimated by experienced physician and anthropologist. Blood samples were taken at 7.30–8.30 a.m., after 8h fasting. The serum concentrations of IGF-I were measured by RIA; IGFBP-1 and IGFBP-3 concentrations by IRMA and HbA1c by HPLC method. The data were analysed using test t-Student, ANOVA, linear and multiple regression analyses.
RESULTS. The diabetic patients’ height did not differ from the height of healthy children and adolescents. At the onset of diabetes patients were not significantly taller than their healthy contemporaries but with the disease duration progress their growth slowly decreased and finally they reached lower level of height than in the control group (the difference didn’t reach statistical significance). Sexual maturation of diabetic patients did not differ from age related healthy polish population independently of diabetes duration. All diabetic and healthy children’s z score of height were higher than z score of mid-parental height. IGF-I concentrations were lower and IGFBP-3 concentrations were higher in diabetic patients than in the control group. IGFBP-1 levels did not differ in both groups. Before the onset of puberty patients’ height correlated with IGF-I, IGFBP-1, and IGFBP-3. In all diabetic patients height correlated with insulin requirement. IGF-1 concentrations correlated also with insulin requirement and HbA1c. Diabetic patients treated with intensive insulinotherapy were slightly taller and had higher IGF-1 and lower IGFBP-1 concentrations than patients treated with other methods of insulinotherapy.
CONCLUSIONS. Somatic development of diabetic children depends not only on genetic influence, but also on adequate insulin substitution which could be achieved by intensive insulinotherapy. Despite decreased IGF-I levels, height within normal ranges was attained, probably because of adequate insulin compensation leading to normal IGFBP-1 levels, thus adequate IGF-I bioavailability.

Abstract

INTRODUCTION. The aim of the study was evaluation of the somatic development and sexual maturation of children and adolescents with type 1 diabetes mellitus and estimation of their IGF-IGFBP system at the on-set of diabetes as well as during the progress of the disease. It was also analysed how the methods of insulinotherapy influence estimated growth factors and auxology parameters.
MATERIAL AND METHODS. 148 diabetic patients without other diseases treated with conventional and intensive insulinotherapy with diabetes duration 0-21 years and 54 age-matched healthy children and adolescents 2–22 years old were included into the study. Their somatic and pubertal development were estimated by experienced physician and anthropologist. Blood samples were taken at 7.30–8.30 a.m., after 8h fasting. The serum concentrations of IGF-I were measured by RIA; IGFBP-1 and IGFBP-3 concentrations by IRMA and HbA1c by HPLC method. The data were analysed using test t-Student, ANOVA, linear and multiple regression analyses.
RESULTS. The diabetic patients’ height did not differ from the height of healthy children and adolescents. At the onset of diabetes patients were not significantly taller than their healthy contemporaries but with the disease duration progress their growth slowly decreased and finally they reached lower level of height than in the control group (the difference didn’t reach statistical significance). Sexual maturation of diabetic patients did not differ from age related healthy polish population independently of diabetes duration. All diabetic and healthy children’s z score of height were higher than z score of mid-parental height. IGF-I concentrations were lower and IGFBP-3 concentrations were higher in diabetic patients than in the control group. IGFBP-1 levels did not differ in both groups. Before the onset of puberty patients’ height correlated with IGF-I, IGFBP-1, and IGFBP-3. In all diabetic patients height correlated with insulin requirement. IGF-1 concentrations correlated also with insulin requirement and HbA1c. Diabetic patients treated with intensive insulinotherapy were slightly taller and had higher IGF-1 and lower IGFBP-1 concentrations than patients treated with other methods of insulinotherapy.
CONCLUSIONS. Somatic development of diabetic children depends not only on genetic influence, but also on adequate insulin substitution which could be achieved by intensive insulinotherapy. Despite decreased IGF-I levels, height within normal ranges was attained, probably because of adequate insulin compensation leading to normal IGFBP-1 levels, thus adequate IGF-I bioavailability.
Get Citation

Keywords

type 1 diabetes mellitus; diabetes on-set; somatic development; sexual maturation; IGF-1; IGFBP-1; IGFBP-3; methods of insulinotherapy; metabolic control of diabetes

About this article
Title

Growing and sexual development and IGF-1, its binding proteins IGFBP-1 and IGFBP-3 in children and adolescents with type 1 diabetes mellitus

Journal

Clinical Diabetology

Issue

Vol 5, No 2 (2004): Practical Diabetology

Pages

57-66

Published online

2004-04-02

Bibliographic record

Diabetologia Praktyczna 2004;5(2):57-66.

Keywords

type 1 diabetes mellitus
diabetes on-set
somatic development
sexual maturation
IGF-1
IGFBP-1
IGFBP-3
methods of insulinotherapy
metabolic control of diabetes

Authors

Anna Wędrychowicz
Hanna Dziatkowiak
Joanna Nazim
Krystyna Sztefko

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl